tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Korro Bio Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsKorro Bio Reports Q1 2025 Financial Results
3M ago
Korro Bio price target lowered to $53 from $130 at H.C. Wainwright
Premium
The Fly
Korro Bio price target lowered to $53 from $130 at H.C. Wainwright
3M ago
Korro Bio price target lowered to $100 from $115 at H.C. Wainwright
Premium
The Fly
Korro Bio price target lowered to $100 from $115 at H.C. Wainwright
3M ago
Korro Bio initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyKorro Bio initiated with an Overweight at Cantor Fitzgerald
3M ago
Korro Bio initiated with a Buy at Chardan
Premium
The Fly
Korro Bio initiated with a Buy at Chardan
3M ago
Korro Bio appoints Loic Vincent as Chief Scientific Officer
Premium
The Fly
Korro Bio appoints Loic Vincent as Chief Scientific Officer
4M ago
Korro Bio reports FY24 EPS ($9.37), consensus ($9.73)
PremiumThe FlyKorro Bio reports FY24 EPS ($9.37), consensus ($9.73)
4M ago
Korro Bio receives ODD from U.S. FDA for AATD
Premium
The Fly
Korro Bio receives ODD from U.S. FDA for AATD
4M ago
Korro Bio’s treatment of alpha-1 antitrypsin deficiency gets orphan designation
Premium
The Fly
Korro Bio’s treatment of alpha-1 antitrypsin deficiency gets orphan designation
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100